Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based ...
(PR-inside.com) Learn how FibroBiologics is developing an off-the-shelf therapeutic platform designed to harness the regenerative and immune-modulating properties of fibroblasts Management to discuss the ongoing Phase 1/2 diabetic foot ulcer trial, upcoming clinical catalysts, broader pipeline opportunities, and an int…
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


